Point72 Asset Management
RDY icon

Point72 Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Point72 Asset Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,000
Closed -$167K – 2544
2023
Q4 		$167K Buy
+12,000
New +$160K ﹤0.01% 1851
2019
Q4 		– Sell
-39,100
Closed -$296K – 1203
2019
Q3 		$296K Buy
+39,100
New +$291K ﹤0.01% 855
2019
Q1 		– Sell
-83,750
Closed -$631K – 1194
2018
Q4 		$631K Buy
+83,750
New +$589K ﹤0.01% 854

Other funds holding RDY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Point72 Asset Management's RDY Position: Q1 2024 in Review

Point72 Asset Management sold out of Dr. Reddy's Laboratories (RDY) in Q1 2024, closing a stake of 12,000 shares — an estimated $167K sold.

Point72 Asset Management first reported a position in RDY in Q4 2018 and held it in 3 quarters. The position peaked at $631K in Q4 2018. 231 funds tracked by Wall St. Rank hold RDY as of Q1 2024.

  • Point72 Asset Management reported no remaining Dr. Reddy's Laboratories position as of Q1 2024 after selling out during the quarter.
  • Point72 Asset Management sold 12,000 Dr. Reddy's Laboratories shares in Q1 2024, an estimated $167K.
  • Point72 Asset Management first reported a position in Dr. Reddy's Laboratories in Q4 2018 and held it in 3 quarters.
  • Point72 Asset Management's Dr. Reddy's Laboratories position peaked at $631K in Q4 2018.
  • 231 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2024.

Based on Point72 Asset Management's 13F filing for Q1 2024, filed 15 May 2024.